Skip to main content
Erschienen in: Pediatric Radiology 4/2024

17.08.2023 | ESPR Belgrade 2023 - Postgraduate Course and Taskforce Lectures

Lung infections in immunocompromised children

verfasst von: Alistair D. Calder, Giulia Perucca, Sarah May Johnson, Ashwin R. Pandey, Karyn Moshal, Maaike A. Kusters

Erschienen in: Pediatric Radiology | Ausgabe 4/2024

Einloggen, um Zugang zu erhalten

Abstract

Pulmonary infection is the leading cause of infectious morbidity and mortality in children with immune defects. We provide a comprehensive review of lung infections in immunocompromised children, with a focus on imaging findings and imaging-based management. We include an overview of the immune defences of the respiratory tract, the aetiologies of immune defects in children, the features of specific infections and important differential diagnoses and describe diagnostic strategies using imaging and non-imaging-based techniques.

Graphical Abstract

Literatur
1.
Zurück zum Zitat Resnick ES, Moshier EL, Godbold JH, Cunningham-Rundles C (2012) Morbidity and mortality in common variable immune deficiency over 4 decades. Blood 119:1650–7PubMedPubMedCentralCrossRef Resnick ES, Moshier EL, Godbold JH, Cunningham-Rundles C (2012) Morbidity and mortality in common variable immune deficiency over 4 decades. Blood 119:1650–7PubMedPubMedCentralCrossRef
2.
Zurück zum Zitat Jesenak M, Banovcin P, Jesenakova B, Babusikova E (2014) Pulmonary manifestations of primary immunodeficiency disorders in children. Front Pediatr 25:77 Jesenak M, Banovcin P, Jesenakova B, Babusikova E (2014) Pulmonary manifestations of primary immunodeficiency disorders in children. Front Pediatr 25:77
3.
5.
Zurück zum Zitat Bousfiha A, Moundir A, Tangye SG et al (2022) The 2022 update of IUIS phenotypical classification for human inborn errors of immunity. J Clin Immunol 42:1508–1520PubMedCrossRef Bousfiha A, Moundir A, Tangye SG et al (2022) The 2022 update of IUIS phenotypical classification for human inborn errors of immunity. J Clin Immunol 42:1508–1520PubMedCrossRef
6.
Zurück zum Zitat Verhagen MV, Trevisan V, Adu J et al (2020) Chest radiographs for distinguishing ADA-SCID from other forms of SCID. J Clin Immunol 40:259–266PubMedCrossRef Verhagen MV, Trevisan V, Adu J et al (2020) Chest radiographs for distinguishing ADA-SCID from other forms of SCID. J Clin Immunol 40:259–266PubMedCrossRef
7.
Zurück zum Zitat Jończyk-Potoczna K, Potoczny J, Szczawińska-Popłonyk A (2022) Imaging in children with ataxia-telangiectasia-the radiologist’s approach. Front Pediatr 10:988645PubMedPubMedCentralCrossRef Jończyk-Potoczna K, Potoczny J, Szczawińska-Popłonyk A (2022) Imaging in children with ataxia-telangiectasia-the radiologist’s approach. Front Pediatr 10:988645PubMedPubMedCentralCrossRef
9.
Zurück zum Zitat Haidopoulou K, Calder A, Jones A, Jaffe A, Sonnappa S (2009) Bronchiectasis secondary to primary immunodeficiency in children: longitudinal changes in structure and function. Pediatr Pulmonol 44:669–675PubMedCrossRef Haidopoulou K, Calder A, Jones A, Jaffe A, Sonnappa S (2009) Bronchiectasis secondary to primary immunodeficiency in children: longitudinal changes in structure and function. Pediatr Pulmonol 44:669–675PubMedCrossRef
10.
Zurück zum Zitat Szczawinska-Popłonyk A, Ta polska-Jóźwiak K, Schwartzmann E, Popłonyk N (2022) Immune dysregulation in pediatric common variable immunodeficiency: implications for the diagnostic approach. Front Pediatr 10:855200PubMedPubMedCentralCrossRef Szczawinska-Popłonyk A, Ta polska-Jóźwiak K, Schwartzmann E, Popłonyk N (2022) Immune dysregulation in pediatric common variable immunodeficiency: implications for the diagnostic approach. Front Pediatr 10:855200PubMedPubMedCentralCrossRef
11.
Zurück zum Zitat Lehman HK (2015) Autoimmunity and immune dysregulation in primary immune deficiency disorders. Curr Allergy Asthma Rep 15:53PubMedCrossRef Lehman HK (2015) Autoimmunity and immune dysregulation in primary immune deficiency disorders. Curr Allergy Asthma Rep 15:53PubMedCrossRef
12.
Zurück zum Zitat Marciano BE, Spalding C, Fitzgerald A et al (2015) Common severe infections in chronic granulomatous disease. Clin Infect Dis 60:1176–83PubMedCrossRef Marciano BE, Spalding C, Fitzgerald A et al (2015) Common severe infections in chronic granulomatous disease. Clin Infect Dis 60:1176–83PubMedCrossRef
13.
Zurück zum Zitat Bennett N, Maglione PJ, Wright BL, Zerbe C (2018) Infectious complications in patients with chronic granulomatous disease. J Pediatric Infect Dis Soc 7:S12–S17PubMedPubMedCentralCrossRef Bennett N, Maglione PJ, Wright BL, Zerbe C (2018) Infectious complications in patients with chronic granulomatous disease. J Pediatric Infect Dis Soc 7:S12–S17PubMedPubMedCentralCrossRef
14.
Zurück zum Zitat Yao Q, Zhou QH, Shen QL et al (2020) Imaging findings of pulmonary manifestations of chronic granulomatous disease in a large single center from Shanghai, China (1999–2018). Sci Rep 10:19349PubMedPubMedCentralCrossRef Yao Q, Zhou QH, Shen QL et al (2020) Imaging findings of pulmonary manifestations of chronic granulomatous disease in a large single center from Shanghai, China (1999–2018). Sci Rep 10:19349PubMedPubMedCentralCrossRef
15.
Zurück zum Zitat Yao Q, Zhou QH, Shen QL et al (2022) Imaging characteristics of pulmonary BCG/TB infection in patients with chronic granulomatous disease. Sci Rep 12:11765PubMedPubMedCentralCrossRef Yao Q, Zhou QH, Shen QL et al (2022) Imaging characteristics of pulmonary BCG/TB infection in patients with chronic granulomatous disease. Sci Rep 12:11765PubMedPubMedCentralCrossRef
16.
Zurück zum Zitat Noma K, Mizoguchi Y, Tsumura M, Okada S (2022) Mendelian susceptibility to mycobacterial diseases: state of the art. Clin Microbiol Infect 28:1429 (Erratum in: Clin Microbiol Infect. 2022 Oct 20) Noma K, Mizoguchi Y, Tsumura M, Okada S (2022) Mendelian susceptibility to mycobacterial diseases: state of the art. Clin Microbiol Infect 28:1429 (Erratum in: Clin Microbiol Infect. 2022 Oct 20)
17.
Zurück zum Zitat Voulgaridou A, Athanasiadou KI, Athanasiadou E et al (2020) Pulmonary infectious complications in children with hematologic malignancies and chemotherapy-induced neutropenia. Diseases 8:32PubMedPubMedCentralCrossRef Voulgaridou A, Athanasiadou KI, Athanasiadou E et al (2020) Pulmonary infectious complications in children with hematologic malignancies and chemotherapy-induced neutropenia. Diseases 8:32PubMedPubMedCentralCrossRef
18.
Zurück zum Zitat Bupha-Intr O, Haeusler G, Chee L et al (2021) CAR-T cell therapy and infection: a review. Expert Rev Anti Infect Ther 19:749–758PubMedCrossRef Bupha-Intr O, Haeusler G, Chee L et al (2021) CAR-T cell therapy and infection: a review. Expert Rev Anti Infect Ther 19:749–758PubMedCrossRef
19.
Zurück zum Zitat Vora SB, Waghmare A, Englund JA et al (2020) Infectious complications following CD19 chimeric antigen receptor T-cell therapy for children, adolescents, and young adults. Open Forum Infect Dis 7:ofaa121PubMedPubMedCentralCrossRef Vora SB, Waghmare A, Englund JA et al (2020) Infectious complications following CD19 chimeric antigen receptor T-cell therapy for children, adolescents, and young adults. Open Forum Infect Dis 7:ofaa121PubMedPubMedCentralCrossRef
20.
Zurück zum Zitat Donnelly JP, Chen SC, Kauffman CA et al (2020) Revision and update of the consensus definitions of invasive fungal disease from the european organization for research and treatment of cancer and the mycoses study group education and research consortium. Clin Infect Dis 71:1367–1376PubMedCrossRef Donnelly JP, Chen SC, Kauffman CA et al (2020) Revision and update of the consensus definitions of invasive fungal disease from the european organization for research and treatment of cancer and the mycoses study group education and research consortium. Clin Infect Dis 71:1367–1376PubMedCrossRef
21.
Zurück zum Zitat Saxena S, Gee J, Klieger S et al (2018) Invasive fungal disease in pediatric solid organ transplant recipients. J Pediatric Infect Dis Soc 7:219–225PubMedCrossRef Saxena S, Gee J, Klieger S et al (2018) Invasive fungal disease in pediatric solid organ transplant recipients. J Pediatric Infect Dis Soc 7:219–225PubMedCrossRef
22.
Zurück zum Zitat Toussi SS, Pan N, Walters HM, Walsh TJ (2013) Infections in children and adolescents with juvenile idiopathic arthritis and inflammatory bowel disease treated with tumor necrosis factor-α inhibitors: systematic review of the literature. Clin Infect Dis 57:1318–30PubMedPubMedCentralCrossRef Toussi SS, Pan N, Walters HM, Walsh TJ (2013) Infections in children and adolescents with juvenile idiopathic arthritis and inflammatory bowel disease treated with tumor necrosis factor-α inhibitors: systematic review of the literature. Clin Infect Dis 57:1318–30PubMedPubMedCentralCrossRef
23.
Zurück zum Zitat Vonasek BJ, Rabie H, Hesseling AC, Garcia-Prats AJ (2022) Tuberculosis in children living with HIV: ongoing progress and challenges. J Pediatric Infect Dis Soc 11:S72–S78PubMedCrossRef Vonasek BJ, Rabie H, Hesseling AC, Garcia-Prats AJ (2022) Tuberculosis in children living with HIV: ongoing progress and challenges. J Pediatric Infect Dis Soc 11:S72–S78PubMedCrossRef
24.
Zurück zum Zitat Horger M, Hebart H, Einsele H et al (2005) Initial CT manifestations of invasive pulmonary aspergillosis in 45 non-HIV immunocompromised patients: association with patient outcome? Eur J Radiol 55:437–444PubMedCrossRef Horger M, Hebart H, Einsele H et al (2005) Initial CT manifestations of invasive pulmonary aspergillosis in 45 non-HIV immunocompromised patients: association with patient outcome? Eur J Radiol 55:437–444PubMedCrossRef
25.
Zurück zum Zitat Burgos A, Zaoutis TE, Dvorak CC et al (2008) Pediatric invasive aspergillosis: a multicenter retrospective analysis of 139 contemporary cases. Pediatrics 121:e1286–e1294PubMedCrossRef Burgos A, Zaoutis TE, Dvorak CC et al (2008) Pediatric invasive aspergillosis: a multicenter retrospective analysis of 139 contemporary cases. Pediatrics 121:e1286–e1294PubMedCrossRef
26.
Zurück zum Zitat Taccone A, Occhi M, Garaventa A et al (1993) CT of invasive pulmonary aspergillosis in children with cancer. Pediatr Radiol 23:177–180PubMedCrossRef Taccone A, Occhi M, Garaventa A et al (1993) CT of invasive pulmonary aspergillosis in children with cancer. Pediatr Radiol 23:177–180PubMedCrossRef
27.
Zurück zum Zitat Thomas KE, Owens CM, Veys PA et al (2003) The radiological spectrum of invasive aspergillosis in children: a 10-year review. Pediatr Radiol 33:453–460PubMedCrossRef Thomas KE, Owens CM, Veys PA et al (2003) The radiological spectrum of invasive aspergillosis in children: a 10-year review. Pediatr Radiol 33:453–460PubMedCrossRef
28.
Zurück zum Zitat Katragkou A, Fisher BT, Groll AH et al (2017) Diagnostic imaging and invasive fungal diseases in children. J Pediatric Infect Dis Soc 6:S22–S31PubMedCrossRef Katragkou A, Fisher BT, Groll AH et al (2017) Diagnostic imaging and invasive fungal diseases in children. J Pediatric Infect Dis Soc 6:S22–S31PubMedCrossRef
29.
Zurück zum Zitat Bain V, Barrientos ACMGA, Suzuki L et al (2022) Radiological patterns of pulmonary fungal infection in pediatric hematology and oncology patients. Radiol Bras 55:78–83PubMedPubMedCentralCrossRef Bain V, Barrientos ACMGA, Suzuki L et al (2022) Radiological patterns of pulmonary fungal infection in pediatric hematology and oncology patients. Radiol Bras 55:78–83PubMedPubMedCentralCrossRef
30.
Zurück zum Zitat Han SB, Kim SK, Bae EY et al (2015) Clinical features and prognosis of invasive pulmonary aspergillosis in Korean children with hematologic/oncologic diseases. J Korean Med Sci 30:1121–8PubMedPubMedCentralCrossRef Han SB, Kim SK, Bae EY et al (2015) Clinical features and prognosis of invasive pulmonary aspergillosis in Korean children with hematologic/oncologic diseases. J Korean Med Sci 30:1121–8PubMedPubMedCentralCrossRef
32.
33.
Zurück zum Zitat Toma P, Bertaina A, Castagnola E et al (2016) Fungal infections of the lung in children. Pediatr Radiol 46:1856–1865PubMedCrossRef Toma P, Bertaina A, Castagnola E et al (2016) Fungal infections of the lung in children. Pediatr Radiol 46:1856–1865PubMedCrossRef
34.
Zurück zum Zitat Guo S, Liu H, Tang X, Yang H (2019) Clinical characteristics and prognoses of pulmonary mucormycosis in four children. Pediatr Investig 3:223–227PubMedPubMedCentralCrossRef Guo S, Liu H, Tang X, Yang H (2019) Clinical characteristics and prognoses of pulmonary mucormycosis in four children. Pediatr Investig 3:223–227PubMedPubMedCentralCrossRef
35.
Zurück zum Zitat Lehrnbecher T, Schöning S, Poyer F et al (2019) Incidence and outcome of invasive fungal diseases in children with hematological malignancies and/or allogeneic hematopoietic stem cell transplantation: results of a prospective multicenter study. Front Microbiol 16:681CrossRef Lehrnbecher T, Schöning S, Poyer F et al (2019) Incidence and outcome of invasive fungal diseases in children with hematological malignancies and/or allogeneic hematopoietic stem cell transplantation: results of a prospective multicenter study. Front Microbiol 16:681CrossRef
36.
Zurück zum Zitat Caselli D, Petris MG, Rondelli R et al (2014) Single-day trimethoprim/sulfamethoxazole prophylaxis for pneumocystis pneumonia in children with cancer. J Pediatr 164:389–392PubMedCrossRef Caselli D, Petris MG, Rondelli R et al (2014) Single-day trimethoprim/sulfamethoxazole prophylaxis for pneumocystis pneumonia in children with cancer. J Pediatr 164:389–392PubMedCrossRef
37.
Zurück zum Zitat Mantadakis E (2020) Pneumocystis jirovecii pneumonia in children with hematological malignancies: diagnosis and approaches to management. J Fungi (Basel) 6:331PubMedCrossRef Mantadakis E (2020) Pneumocystis jirovecii pneumonia in children with hematological malignancies: diagnosis and approaches to management. J Fungi (Basel) 6:331PubMedCrossRef
38.
Zurück zum Zitat Restrepo-Gualteros SM, Gutierrez MJ, Villamil-Osorio M et al (2019) Challenges and clinical implications of the diagnosis of cytomegalovirus lung infection in children. Curr Infect Dis Rep 21:24PubMedPubMedCentralCrossRef Restrepo-Gualteros SM, Gutierrez MJ, Villamil-Osorio M et al (2019) Challenges and clinical implications of the diagnosis of cytomegalovirus lung infection in children. Curr Infect Dis Rep 21:24PubMedPubMedCentralCrossRef
39.
Zurück zum Zitat Yeh TJ, Yang CI, Huang CT et al (2022) Revisit of the association between cytomegalovirus infection and invasive fungal infection after allogeneic hematopoietic stem cell transplantation: a real-world analysis from a high CMV seroprevalence area. J Fungi (Basel) 8:408PubMedCrossRef Yeh TJ, Yang CI, Huang CT et al (2022) Revisit of the association between cytomegalovirus infection and invasive fungal infection after allogeneic hematopoietic stem cell transplantation: a real-world analysis from a high CMV seroprevalence area. J Fungi (Basel) 8:408PubMedCrossRef
40.
Zurück zum Zitat SeyedAlinaghi S, Karimi A, Barzegary A et al (2022) COVID-19 mortality in patients with immunodeficiency and its predictors: a systematic review. Eur J Med Res 27:195PubMedPubMedCentralCrossRef SeyedAlinaghi S, Karimi A, Barzegary A et al (2022) COVID-19 mortality in patients with immunodeficiency and its predictors: a systematic review. Eur J Med Res 27:195PubMedPubMedCentralCrossRef
41.
Zurück zum Zitat Zhang Q, Bastard P, Liu Z et al (2020) Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science 370:4570CrossRef Zhang Q, Bastard P, Liu Z et al (2020) Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science 370:4570CrossRef
42.
Zurück zum Zitat Shields AM, Anantharachagan A, Arumugakani G et al (2022) Outcomes following SARS-CoV-2 infection in patients with primary and secondary immunodeficiency in the UK. Clin Exp Immunol 209:247–258PubMedPubMedCentralCrossRef Shields AM, Anantharachagan A, Arumugakani G et al (2022) Outcomes following SARS-CoV-2 infection in patients with primary and secondary immunodeficiency in the UK. Clin Exp Immunol 209:247–258PubMedPubMedCentralCrossRef
43.
Zurück zum Zitat Chappell H, Patel R, Driessens C et al (2022) Immunocompromised children and young people are at no increased risk of severe COVID-19. J Infect. 84(1):31–39.PubMedCrossRef Chappell H, Patel R, Driessens C et al (2022) Immunocompromised children and young people are at no increased risk of severe COVID-19. J Infect. 84(1):31–39.PubMedCrossRef
44.
Zurück zum Zitat Shrot S, Barkai G, Ben-Shlush A, Soudack M (2016) BCGitis and BCGosis in children with primary immunodeficiency - imaging characteristics. Pediatr Radiol 46:237–245PubMedCrossRef Shrot S, Barkai G, Ben-Shlush A, Soudack M (2016) BCGitis and BCGosis in children with primary immunodeficiency - imaging characteristics. Pediatr Radiol 46:237–245PubMedCrossRef
45.
Zurück zum Zitat Naidoo J, Mahomed N, Moodley H (2017) A systemic review of tuberculosis with HIV coinfection in children. Pediatr Radiol 47:1269–1276PubMedCrossRef Naidoo J, Mahomed N, Moodley H (2017) A systemic review of tuberculosis with HIV coinfection in children. Pediatr Radiol 47:1269–1276PubMedCrossRef
46.
47.
Zurück zum Zitat Boisson-Dupuis S, Bustamante J, El-Baghdadi J et al (2015) Inherited and acquired immunodeficiencies underlying tuberculosis in childhood. Immunol Rev 264:103–120PubMedPubMedCentralCrossRef Boisson-Dupuis S, Bustamante J, El-Baghdadi J et al (2015) Inherited and acquired immunodeficiencies underlying tuberculosis in childhood. Immunol Rev 264:103–120PubMedPubMedCentralCrossRef
48.
Zurück zum Zitat Tamburro RF, Cooke KR, Davies SM et al (2021) Pulmonary complications of pediatric hematopoietic stem cell transplantation workshop participants. pulmonary complications of pediatric hematopoietic cell transplantation. A National Institutes of Health Workshop Summary. Ann Am Thorac Soc 18:381–394PubMedPubMedCentralCrossRef Tamburro RF, Cooke KR, Davies SM et al (2021) Pulmonary complications of pediatric hematopoietic stem cell transplantation workshop participants. pulmonary complications of pediatric hematopoietic cell transplantation. A National Institutes of Health Workshop Summary. Ann Am Thorac Soc 18:381–394PubMedPubMedCentralCrossRef
49.
Zurück zum Zitat Broglie L, Fretham C, Al-Seraihy A et al (2019) Pulmonary complications in pediatric and adolescent patients following allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 25:2024–2030PubMedPubMedCentralCrossRef Broglie L, Fretham C, Al-Seraihy A et al (2019) Pulmonary complications in pediatric and adolescent patients following allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 25:2024–2030PubMedPubMedCentralCrossRef
50.
Zurück zum Zitat Yoshihara S, Yanik G, Cooke KR, Mineishi S (2007) Bronchiolitis obliterans syndrome (BOS), bronchiolitis obliterans organizing pneumonia (BOOP), and other late-onset noninfectious pulmonary complications following allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 13:749–759PubMedCrossRef Yoshihara S, Yanik G, Cooke KR, Mineishi S (2007) Bronchiolitis obliterans syndrome (BOS), bronchiolitis obliterans organizing pneumonia (BOOP), and other late-onset noninfectious pulmonary complications following allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 13:749–759PubMedCrossRef
51.
Zurück zum Zitat Leonard JT, Newell LF, Meyers G et al (2015) Chronic GvHD-associated serositis and pericarditis. Bone Marrow Transplant 50:1098–1104PubMedCrossRef Leonard JT, Newell LF, Meyers G et al (2015) Chronic GvHD-associated serositis and pericarditis. Bone Marrow Transplant 50:1098–1104PubMedCrossRef
52.
Zurück zum Zitat Rodina Y, Deripapa E, Shvets O et al (2021) Rituximab and abatacept are effective in differential treatment of interstitial lymphocytic lung disease in children with primary immunodeficiencies. Front Immunol 12:704261PubMedPubMedCentralCrossRef Rodina Y, Deripapa E, Shvets O et al (2021) Rituximab and abatacept are effective in differential treatment of interstitial lymphocytic lung disease in children with primary immunodeficiencies. Front Immunol 12:704261PubMedPubMedCentralCrossRef
53.
Zurück zum Zitat Grunebaum E, Cutz E, Roifman CM (2012) Pulmonary alveolar proteinosis in patients with adenosine deaminase deficiency. J Allergy Clin Immunol 129:1588–1593PubMedCrossRef Grunebaum E, Cutz E, Roifman CM (2012) Pulmonary alveolar proteinosis in patients with adenosine deaminase deficiency. J Allergy Clin Immunol 129:1588–1593PubMedCrossRef
54.
Zurück zum Zitat Gao X, Michel K, Griese M (2022) Interstitial lung disease in immunocompromised children. Diagnostics (Basel) 13:64PubMedCrossRef Gao X, Michel K, Griese M (2022) Interstitial lung disease in immunocompromised children. Diagnostics (Basel) 13:64PubMedCrossRef
55.
Zurück zum Zitat Hsu AJ, Tamma PD, Zhang SX (2021) Challenges with utilizing the 1,3-beta-d-glucan and galactomannan assays to diagnose invasive mold infections in immunocompromised children. J Clin Microbiol. 59(9):e0327620PubMedCrossRef Hsu AJ, Tamma PD, Zhang SX (2021) Challenges with utilizing the 1,3-beta-d-glucan and galactomannan assays to diagnose invasive mold infections in immunocompromised children. J Clin Microbiol. 59(9):e0327620PubMedCrossRef
56.
Zurück zum Zitat Onishi A, Sugiyama D, Kogata Y et al (2012) Diagnostic accuracy of serum 1,3-β-D-glucan for Pneumocystis jirovecii pneumonia, invasive candidiasis, and invasive aspergillosis: systematic review and meta-analysis. J Clin Microbiol 50:7–15PubMedPubMedCentralCrossRef Onishi A, Sugiyama D, Kogata Y et al (2012) Diagnostic accuracy of serum 1,3-β-D-glucan for Pneumocystis jirovecii pneumonia, invasive candidiasis, and invasive aspergillosis: systematic review and meta-analysis. J Clin Microbiol 50:7–15PubMedPubMedCentralCrossRef
57.
Zurück zum Zitat Leeflang MM, Debets-Ossenkopp YJ et al (2015) Galactomannan detection for invasive aspergillosis in immunocompromised patients. Cochrane Database Syst Rev 2015:007394 Leeflang MM, Debets-Ossenkopp YJ et al (2015) Galactomannan detection for invasive aspergillosis in immunocompromised patients. Cochrane Database Syst Rev 2015:007394
58.
Zurück zum Zitat Esposito S, Mencacci A et al (2019) Multiplex platforms for the identification of respiratory pathogens: are they useful in pediatric clinical practice? Front Cell Infect Microbiol 4:196CrossRef Esposito S, Mencacci A et al (2019) Multiplex platforms for the identification of respiratory pathogens: are they useful in pediatric clinical practice? Front Cell Infect Microbiol 4:196CrossRef
59.
Zurück zum Zitat Naureckas Li C, Nakamura MM (2022) Utility of broad-range PCR sequencing for infectious diseases clinical decision making: a pediatric center experience. J Clin Microbiol 60:e0243721PubMedCrossRef Naureckas Li C, Nakamura MM (2022) Utility of broad-range PCR sequencing for infectious diseases clinical decision making: a pediatric center experience. J Clin Microbiol 60:e0243721PubMedCrossRef
60.
Zurück zum Zitat Tschiedel E, Goralski A, Steinmann J et al (2019) Multiplex PCR of bronchoalveolar lavage fluid in children enhances the rate of pathogen detection. BMC Pulm Med 19:132.PubMedPubMedCentralCrossRef Tschiedel E, Goralski A, Steinmann J et al (2019) Multiplex PCR of bronchoalveolar lavage fluid in children enhances the rate of pathogen detection. BMC Pulm Med 19:132.PubMedPubMedCentralCrossRef
61.
Zurück zum Zitat Stefanutti D, Morais L, Fournet JC et al (2000) Value of open lung biopsy in immunocompromised children. J Pediatr 137:165–171PubMedCrossRef Stefanutti D, Morais L, Fournet JC et al (2000) Value of open lung biopsy in immunocompromised children. J Pediatr 137:165–171PubMedCrossRef
62.
Zurück zum Zitat Naiditch JA, Barsness KA, Rothstein DH (2013) The utility of surgical lung biopsy in immunocompromised children. J Pediatr 162:133–6.e1PubMedCrossRef Naiditch JA, Barsness KA, Rothstein DH (2013) The utility of surgical lung biopsy in immunocompromised children. J Pediatr 162:133–6.e1PubMedCrossRef
63.
Zurück zum Zitat Ozcan HN, Gormez A, Ozsurekci Y et al (2017) Magnetic resonance imaging of pulmonary infection in immunocompromised children: comparison with multidetector computed tomography. Pediatr Radiol 47:146–153PubMedCrossRef Ozcan HN, Gormez A, Ozsurekci Y et al (2017) Magnetic resonance imaging of pulmonary infection in immunocompromised children: comparison with multidetector computed tomography. Pediatr Radiol 47:146–153PubMedCrossRef
Metadaten
Titel
Lung infections in immunocompromised children
verfasst von
Alistair D. Calder
Giulia Perucca
Sarah May Johnson
Ashwin R. Pandey
Karyn Moshal
Maaike A. Kusters
Publikationsdatum
17.08.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Radiology / Ausgabe 4/2024
Print ISSN: 0301-0449
Elektronische ISSN: 1432-1998
DOI
https://doi.org/10.1007/s00247-023-05735-1

Weitere Artikel der Ausgabe 4/2024

Pediatric Radiology 4/2024 Zur Ausgabe

ESPR Belgrade 2023 - Postgraduate Course and Taskforce Lectures

Unusual pediatric lung infections: imaging findings

Letter to the Editor

Reply to De Palma D

Hermes

Hermes

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.